Sandor Schoichet, an independent advisor, and director of Meridian Management Consultants based in San Francisco, and Pharm Exec’s Sustainability columnist, and his co-collaborator, Thomas Scheiwiller, an independent advisor and board member based in Zurich, discuss many of the topics we touch on today in regard to biopharma’s approach to integrating environmental, social, and governance, or ESG, issues into business strategy.
Pharmaceutical Executive